Retail sales of inhalation devices in European countries: So much for a global policy

Respiratory Medicine

Volumn 105, Issue 7, 2011, Pages 1099-1103

  Lavorini, F ^a   Corrigan, C J ^b   Barnes, P J ^c   Dekhuijzen, P R N ^d   Levy, M L ^e   Pedersen, S ^f   Roche, N ^g   Vincken, W ^h   Crompton, G K ⁱ  

^a UNIVERSITY OF FLORENCE   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f KOLDING HOSPITAL   (Denmark)

^g HÔTEL DIEU   (France)

^h University Hospital UZBrussel   (Belgium)

ⁱ WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Dry powder inhaler; Nebuliser; Prescriptions; Pressurised metered dose inhaler; Sales

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; EUROPE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; HUNGARY; ITALY; MEDICAL NEBULIZER; METERED DOSE INHALER; NEBULIZATION; PHARMACY; POWDER INHALER; PRESCRIPTION; PRIORITY JOURNAL; PURCHASING; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; ASTHMA; BRONCHODILATOR AGENTS; DRY POWDER INHALERS; EUROPE; FEMALE; HEALTH POLICY; HUMANS; MALE; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79957454222     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.03.012     Document Type: Article

References (20)

1. http://www.admit-online.info/en/inhalation-systems/choose-device/ overview-inhalation-devices.
2. M. Molimard, C. Raherison, S. Lignot, F. Depont, A. Abouelfath, and N. Moore Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care J Aerosol Med 16 2003 249 254 (Pubitemid 37169635)
3. G.K. Crompton, P.J. Barnes, and M. Broeders The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team Respir Med 100 2006 1479 1494 (Pubitemid 44109117)
4. F. Lavorini, A. Magnan, and J.C. Dubus Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD Respir Med 102 2008 593 604
5. K. Rabe, P. Vermeire, J. Soriano, and W. Maier Clinical management of asthma in 1999: the asthma Insights and Reality in Europe (AIRE) study Eur Respir J 16 2000 802 807 (Pubitemid 32049363)
6. J.C. Virchow, G.K. Crompton, R. Dal Negro, S. Pedersen, A. Magnan, J. Seidenberg, and P.J. Barnes Importance of inhaler devices in the management of airway disease Respir Med 102 2008 10 19 (Pubitemid 350161842)
7. J. Haughney, D. Price, N.C. Barnes, J.C. Virchow, N. Roche, and H. Chrystyn Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs Respir Med 104 2010 1237 1245
8. C.L. Leach, P.J. Davidson, B.E. Hasselquist, and R.G. Boudreau Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers Chest 122 2002 510 516 (Pubitemid 35002128)
9. A.J. Morton-Jones, and M.A.L. Pringle Explaining variations in prescribing costs across England Brit Med J 306 1993 1731 1734
10. D.P. Forster, and C.E.B. Frost Use of regression analysis to explain the variation in prescribing rates and costs between family practitioner committees J Gen Pract 41 1991 67 71
11. National Institute for Health and Clinical Excellence. Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over. http://www.nice.org.uk/nicemedia/live/11945/40099/40099. pdf.
12. IMS Health databases, IMS-DA: electronic medical records on adults and children. http://www.imshealth.com.
13. G. Crompton Problems patients have using pressurized aerosol inhalers Eur J Respir Dis 119 1982 101 104 (Pubitemid 12060363)
14. G.K. Crompton, and J. Duncan Clinical assessment of a new breath-activated inhaler Practitioner 233 1989 496 500
15. J. Lenny, J. Innes, and G. Crompton Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices Respir Med 94 2000 496 500 (Pubitemid 30353008)
16. A. Hardwell, V. Barber, T. Hargadon, E. McKnight, J. Holmes, and M.L. Levy Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs) Prim Care Respir J 20 2011 92 96
17. B. Interiano, and K.K. Guntupalli Metered-dose inhalers. Do health care providers know what to teach? Arch Intern Med 153 1993 81 85 (Pubitemid 23043372)
18. N.A. Hanania, R. Wittman, S. Kesten, and K.R. Chapman Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers Chest 105 1994 111 116 (Pubitemid 24029087)
19. J.S. Jones, C.P. Holstege, R. Riekse, L. White, and T. Bergquist Metered-dose inhalers: do emergency health care providers know what to teach? Ann Emerg Med 26 1995 308 311
20. M. Bianchi, A. Clavenna, and L. Labate Anti-asthmatic drug prescriptions to an Italian paediatric population Pediatr Allergy Immunol 20 2008 585 591